Sluiten
Succesfull SARS-Cov-2 Vaccination in patients receiving Systemic Drugs for Skin Disorders
01 February 2021
Should we continue, interrupt, or settle for reduced efficacy?
More and more professionals and patients are seeking for an answer to this question. Please find here a proposition on how to act in case your patient is on a systemic immunosuppressant, based on recent work of Prof. Speeckaert R.
More information and overview in PDF